Research Map
The live state of the reviewed evidence — 1,138 published studies (277 human), 44 cancer pages, and 0 evidence verdicts. Educational only; not medical advice.
Most-studied medicines & supplements
By the number of distinct studies citing each across every cancer page.
- chemotherapy · 115 studies
- platinum-based chemotherapy · 103 studies
- Carboplatin · 89 studies
- Paclitaxel · 52 studies
- Radiotherapy · 47 studies
- Surgery · 47 studies
- Bevacizumab · 34 studies
- Cisplatin · 25 studies
Most-tracked cancers
By the number of studies in each cancer’s cited corpus.
Lung Adenocarcinoma · 3203 studiesBreast Invasive Ductal Carcinoma · 2961 studiesRhabdomyosarcoma · 1834 studiesUterine Leiomyosarcoma · 1743 studiesProstate Cancer · 1656 studiesNeuroblastoma · 1563 studiesColon Cancer · 1562 studiesOvarian Cancer · 1514 studiesMelanoma · 1461 studiesGlioblastoma · 1395 studies
Newest safety signals
- The Future of Minimal-Access Myoma Surgery with In-Bag Contained Morcellation · Journal of clinical medicine · 2023
Formulation & bioavailability
- Radiative magneto-thermal modeling of tri hybrid nanofluid in blood: A Biomedical intelligent framework for hyperthermia cancer therapy · Journal of thermal biology · 2026
- Nanomedicine in Immunotherapy for Non-Small Cell Lung Cancer: Applications and Perspectives · Small methods · 2025
- Promising biomedical applications using superparamagnetic nanoparticles · European journal of medical research · 2025
- Zwitterionic nanoparticles for thermally activated drug delivery in hyperthermia cancer treatment · Nanoscale · 2024
- Stimuli responsive nanosonosensitizers for sonodynamic therapy · Journal of controlled release : official journal of the Controlled Release Society · 2023
- Drug Delivery in Photodynamic Therapy · Pharmaceutics · 2023
Clinical-trial reports
- Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials · Translational cancer research · 2026
- Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study · International journal of radiation oncology, biology, physics · 2026
- Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group · Neuro-oncology · 2025
- Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study · Med (New York, N.Y.) · 2025
- Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
- Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial · Lancet (London, England) · 2025
Recently discovered from the literature
CostunolideMethotrexateMemantineRucaparibDacarbazineEtoposideCrizotinibTrastuzumab-Deruxtecan (T-Dxd)AnastrozoleLenvatinibTaxolDostarlimabIntracranial SarcomaPeritoneal SarcomaOvarian SarcomaProstate AdenocarcinomaMesonephric AdenocarcinomaEndometrioid CarcinomaPulmonary Large Cell Neuroendocrine Carcinoma (Lcnec)Pancreatic CancerLarge-Cell Neuroendocrine CarcinomaRenal SarcomaLeiomyosarcomaUterine Serous Carcinoma
How this is built
Every number and link here is drawn from human-approved, published content — nothing is estimated. Read how we review, or jump into the study feed.